Sisecam announced financial results for the first three months of 2025. In the three-month period, Sisecam's consolidated net sales totaled TRY 45 billion.

First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...

CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in ...

EBITDA of ?462 Cr at 21.4% margin, reflecting consistent operating profitability BENGALURU, India and SEATTLE and LONDON, May 13, 2025 /PRNewswire/ ...